NRx Pharmaceuticals Inc. announced the issuance of approximately $16.3 million in senior secured convertible promissory notes and common stock purchase warrants, along with a registered direct offering of 1,215,278 shares at $2.88 per share, aiming to use the proceeds for general working capital.